230 related articles for article (PubMed ID: 3283555)
1. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.
Tacket CO; Losonsky G; Link H; Hoang Y; Guesry P; Hilpert H; Levine MM
N Engl J Med; 1988 May; 318(19):1240-3. PubMed ID: 3283555
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
Graham DY; Estes MK; Gentry LO
Gastroenterology; 1983 Nov; 85(5):1017-22. PubMed ID: 6352386
[TBL] [Abstract][Full Text] [Related]
3. Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal.
Tacket CO; Losonsky G; Livio S; Edelman R; Crabb J; Freedman D
J Infect Dis; 1999 Dec; 180(6):2056-9. PubMed ID: 10558970
[TBL] [Abstract][Full Text] [Related]
4. Human colostrum contains IgA antibodies reactive to colonization factors I and II of enterotoxigenic Escherichia coli.
Corrêa S; Palmeira P; Carneiro-Sampaio MM; Sanae Nishimura L; Guth BE
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):199-206. PubMed ID: 16831206
[TBL] [Abstract][Full Text] [Related]
5. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man.
Levine MM; Black RE; Brinton CC; Clements ML; Fusco P; Hughes TP; O'Donnell S; Robins-Browne R; Wood S; Young CR
Scand J Infect Dis Suppl; 1982; 33():83-95. PubMed ID: 6127806
[TBL] [Abstract][Full Text] [Related]
6. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
[TBL] [Abstract][Full Text] [Related]
7. Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial.
Casswall TH; Sarker SA; Faruque SM; Weintraub A; Albert MJ; Fuchs GJ; Alam NH; Dahlström AK; Link H; Brüssow H; Hammarström L
Scand J Gastroenterol; 2000 Jul; 35(7):711-8. PubMed ID: 10972174
[TBL] [Abstract][Full Text] [Related]
8. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
Evans DG; Graham DY; Evans DJ
Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
[TBL] [Abstract][Full Text] [Related]
9. Protection of neonatal calves against fatal enteric colibacillosis by administration of egg yolk powder from hens immunized with K99-piliated enterotoxigenic Escherichia coli.
Ikemori Y; Kuroki M; Peralta RC; Yokoyama H; Kodama Y
Am J Vet Res; 1992 Nov; 53(11):2005-8. PubMed ID: 1466492
[TBL] [Abstract][Full Text] [Related]
10. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of immunization with ferric citrate receptor FecA from Escherichia coli on induced coliform mastitis.
Takemura K; Hogan JS; Lin J; Smith KL
J Dairy Sci; 2002 Apr; 85(4):774-81. PubMed ID: 12018422
[TBL] [Abstract][Full Text] [Related]
12. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
13. Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies.
Kariyawasam S; Wilkie BN; Gyles CL
Vet Microbiol; 2004 Mar; 98(3-4):273-84. PubMed ID: 15036536
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiologic, clinical and microbiological characteristics of enterotoxigenic E. coli as the cause of traveller's diarrhea].
Vila J; Gascón J; Gené A; Ruiz L; Corachán M; Jiménez de Anta MT
Enferm Infecc Microbiol Clin; 1992 Mar; 10(3):148-51. PubMed ID: 1576188
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intramammary immunization with an Escherichia coli J5 bacterin.
Smith JL; Hogan JS; Smith KL
J Dairy Sci; 1999 Dec; 82(12):2582-8. PubMed ID: 10629804
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.
McKenzie R; Darsley M; Thomas N; Randall R; Carpenter C; Forbes E; Finucane M; Sack RB; Hall E; Bourgeois AL
Vaccine; 2008 Aug; 26(36):4731-9. PubMed ID: 18602960
[TBL] [Abstract][Full Text] [Related]
17. Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.
Coster TS; Wolf MK; Hall ER; Cassels FJ; Taylor DN; Liu CT; Trespalacios FC; DeLorimier A; Angleberger DR; McQueen CE
Infect Immun; 2007 Jan; 75(1):252-9. PubMed ID: 17074855
[TBL] [Abstract][Full Text] [Related]
18. Vaccines for enterotoxigenic Escherichia coli: current status.
Boedeker EC
Curr Opin Gastroenterol; 2005 Jan; 21(1):15-9. PubMed ID: 15687879
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered monoclonal antibody for E coli diarrhea in calves.
Morter RL
Mod Vet Pract; 1984 Jun; 65(6):427-8. PubMed ID: 6377041
[TBL] [Abstract][Full Text] [Related]
20. Brief prophylaxis with doxycycline for the prevention of traveler's diarrhea.
Freeman LD; Hooper DR; Lathen DF; Nelson DP; Harrison WO; Anderson DS
Gastroenterology; 1983 Feb; 84(2):276-80. PubMed ID: 6336708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
